Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Gains from Investment Securities: 2018-2024

Historic Gains from Investment Securities for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $100,000.

  • Therapeutics' Gains from Investment Securities was N/A to $5.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $100,000 for FY2024, which is 85.71% down from last year.
  • Therapeutics' Gains from Investment Securities amounted to $100,000 in FY2024, which was down 85.71% from $700,000 recorded in FY2023.
  • In the past 5 years, Therapeutics' Gains from Investment Securities registered a high of $8.1 million during FY2022, and its lowest value of $100,000 during FY2024.
  • In the last 3 years, Therapeutics' Gains from Investment Securities had a median value of $700,000 in 2023 and averaged $3.0 million.
  • Per our database at Business Quant, Therapeutics' Gains from Investment Securities spiked by 235.96% in 2022 and then slumped by 91.32% in 2023.
  • Over the past 5 years, Therapeutics' Gains from Investment Securities (Yearly) stood at $2.4 million in 2020, then remained steady at $2.4 million in 2021, then soared by 235.96% to $8.1 million in 2022, then tumbled by 91.32% to $700,000 in 2023, then crashed by 85.71% to $100,000 in 2024.